4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-022859
CHIEF FINANCIAL OFFICER gave up 3,216 shares (to pay taxes)
- CHIEF FINANCIAL OFFICER acquired 6,305 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-09-01 | Option exercise | +4,444 | 24,313 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-09-01 | Shares withheld for taxes | −2,260 | $26.74 | $60,432 | 22,053 | D |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-09-02 | Option exercise | +1,861 | 23,914 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-09-02 | Shares withheld for taxes | −956 | $26.74 | $25,563 | 22,958 | D |
| Derivatives | |||||||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-09-01 | Grant or award · Restricted Share Unit | +6,365 | 6,365 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-09-01 | Grant or award · Share Option | +33,150 | 33,150 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-09-01 | Option exercise · Restricted Share Unit | −2,694 | 5,388 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-09-01 | Option exercise · Restricted Share Unit | −1,750 | 5,250 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2024-09-02 | Option exercise · Restricted Share Unit | −1,861 | 1,861 | D | ||
Loading xslF345X05/form4-09052024_120941.xml…